| Literature DB >> 28380379 |
Cristina Aguayo-Mazzucato1, Mark van Haaren1, Magdalena Mruk1, Terence B Lee1, Caitlin Crawford1, Jennifer Hollister-Lock1, Brooke A Sullivan1, James W Johnson1, Aref Ebrahimi1, Jonathan M Dreyfuss2, Jan Van Deursen3, Gordon C Weir1, Susan Bonner-Weir4.
Abstract
We hypothesized that the known heterogeneity of pancreatic β cells was due to subpopulations of β cells at different stages of their life cycle with different functional capacities and that further changes occur with metabolic stress and aging. We identified new markers of aging in β cells, including IGF1R. In β cells IGF1R expression correlated with age, dysfunction, and expression of known age markers p16ink4a, p53BP1, and senescence-associated β-galactosidase. The new markers showed striking heterogeneity both within and between islets in both mouse and human pancreas. Acute induction of insulin resistance with an insulin receptor antagonist or chronic ER stress resulted in increased expression of aging markers, providing insight into how metabolic stress might accelerate dysfunction and decline of β cells. These novel findings about β cell and islet heterogeneity, and how they change with age, open up an entirely new set of questions about the pathogenesis of type 2 diabetes.Entities:
Keywords: aging markers; beta-cell heterogeneity; islets
Mesh:
Substances:
Year: 2017 PMID: 28380379 PMCID: PMC5471618 DOI: 10.1016/j.cmet.2017.03.015
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287